225 related articles for article (PubMed ID: 34032638)
21. TCR Signal Strength and Antigen Affinity Regulate CD8
Solouki S; Huang W; Elmore J; Limper C; Huang F; August A
J Immunol; 2020 Sep; 205(5):1217-1227. PubMed ID: 32759295
[TBL] [Abstract][Full Text] [Related]
22. TOX defines the degree of CD8+ T cell dysfunction in distinct phases of chronic HBV infection.
Heim K; Binder B; Sagar ; Wieland D; Hensel N; Llewellyn-Lacey S; Gostick E; Price DA; Emmerich F; Vingerhoet H; Kraft ARM; Cornberg M; Boettler T; Neumann-Haefelin C; Zehn D; Bengsch B; Hofmann M; Thimme R
Gut; 2020 Oct; 70(8):1550-60. PubMed ID: 33097558
[TBL] [Abstract][Full Text] [Related]
23. TOX expression in cutaneous T-cell lymphomas: an adjunctive diagnostic marker that is not tumour specific and not restricted to the CD4(+) CD8(-) phenotype.
Schrader AM; Jansen PM; Willemze R
Br J Dermatol; 2016 Aug; 175(2):382-6. PubMed ID: 26931394
[TBL] [Abstract][Full Text] [Related]
24. Non-terminally exhausted tumor-resident memory HBV-specific T cell responses correlate with relapse-free survival in hepatocellular carcinoma.
Cheng Y; Gunasegaran B; Singh HD; Dutertre CA; Loh CY; Lim JQ; Crawford JC; Lee HK; Zhang X; Lee B; Becht E; Lim WJ; Yeong J; Chan CY; Chung A; Goh BKP; Chow PKH; Chan JKY; Ginhoux F; Tai D; Chen J; Lim SG; Zhai W; Choo SP; Newell EW
Immunity; 2021 Aug; 54(8):1825-1840.e7. PubMed ID: 34270940
[TBL] [Abstract][Full Text] [Related]
25. Expression of the DNA-Binding Factor TOX Promotes the Encephalitogenic Potential of Microbe-Induced Autoreactive CD8
Page N; Klimek B; De Roo M; Steinbach K; Soldati H; Lemeille S; Wagner I; Kreutzfeldt M; Di Liberto G; Vincenti I; Lingner T; Salinas G; Brück W; Simons M; Murr R; Kaye J; Zehn D; Pinschewer DD; Merkler D
Immunity; 2018 May; 48(5):937-950.e8. PubMed ID: 29768177
[TBL] [Abstract][Full Text] [Related]
26. Constitutively CD40-activated B cells regulate CD8 T cell inflammatory response by IL-10 induction.
Koni PA; Bolduc A; Takezaki M; Ametani Y; Huang L; Lee JR; Nutt SL; Kamanaka M; Flavell RA; Mellor AL; Tsubata T; Shimoda M
J Immunol; 2013 Apr; 190(7):3189-96. PubMed ID: 23440421
[TBL] [Abstract][Full Text] [Related]
27. TOX: an HMG box protein implicated in the regulation of thymocyte selection.
Wilkinson B; Chen JY; Han P; Rufner KM; Goularte OD; Kaye J
Nat Immunol; 2002 Mar; 3(3):272-80. PubMed ID: 11850626
[TBL] [Abstract][Full Text] [Related]
28. Suppressor of cytokine signaling 1 regulates IL-15 receptor signaling in CD8+CD44high memory T lymphocytes.
Ilangumaran S; Ramanathan S; La Rose J; Poussier P; Rottapel R
J Immunol; 2003 Sep; 171(5):2435-45. PubMed ID: 12928391
[TBL] [Abstract][Full Text] [Related]
29. TOX regulates T lymphocytes differentiation and its function in tumor.
Niu H; Wang H
Front Immunol; 2023; 14():990419. PubMed ID: 36969216
[TBL] [Abstract][Full Text] [Related]
30. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
Duong MN; Erdes E; Hebeisen M; Rufer N
J Immunother Cancer; 2019 Nov; 7(1):284. PubMed ID: 31690351
[TBL] [Abstract][Full Text] [Related]
31. Maintenance of PD-1 on brain-resident memory CD8 T cells is antigen independent.
Shwetank ; Abdelsamed HA; Frost EL; Schmitz HM; Mockus TE; Youngblood BA; Lukacher AE
Immunol Cell Biol; 2017 Nov; 95(10):953-959. PubMed ID: 28829048
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of mRNA Expressions of TOX and NR4As in CD8+ T cells in Acute Leukemia.
Mohammadi M; Asgarian-Omran H; Najafi B; Najafi A; Valadan R; Karami H; Naderisoraki M; Alizadeforoutan M; Shekarriz R; Tehrani M
Iran J Immunol; 2023 Dec; 20(4):438-445. PubMed ID: 37961948
[TBL] [Abstract][Full Text] [Related]
33. Development of all CD4 T lineages requires nuclear factor TOX.
Aliahmad P; Kaye J
J Exp Med; 2008 Jan; 205(1):245-56. PubMed ID: 18195075
[TBL] [Abstract][Full Text] [Related]
34. Dual roles of IL-15 in maintaining IL-7RalphalowCCR7- memory CD8+ T cells in humans via recovering the phosphatidylinositol 3-kinase/AKT pathway.
Kim HR; Hwang KA; Kang I
J Immunol; 2007 Nov; 179(10):6734-40. PubMed ID: 17982063
[TBL] [Abstract][Full Text] [Related]
35. Expression pattern, regulation, and clinical significance of TOX in breast cancer.
Arora M; Kumari S; Singh J; Chopra A; Chauhan SS
Cancer Immunol Immunother; 2021 Feb; 70(2):349-363. PubMed ID: 32757053
[TBL] [Abstract][Full Text] [Related]
36. Molecular profiling of TOX-deficient neoplastic cells in cutaneous T cell lymphoma.
Xu J; Huang H; Wang S; Chen Y; Yin X; Zhang X; Zhang Y
Arch Dermatol Res; 2020 Sep; 312(7):513-525. PubMed ID: 31676945
[TBL] [Abstract][Full Text] [Related]
37. High-mobility group box (TOX) antibody a useful tool for the identification of B and T cell subpopulations.
Maestre L; García-García JF; Jiménez S; Reyes-García AI; García-González Á; Montes-Moreno S; Arribas AJ; González-García P; Caleiras E; Banham AH; Piris MÁ; Roncador G
PLoS One; 2020; 15(2):e0229743. PubMed ID: 32106280
[TBL] [Abstract][Full Text] [Related]
38. The TOX-RAGE axis mediates inflammatory activation and lung injury in severe pulmonary infectious diseases.
Kim H; Park HH; Kim HN; Seo D; Hong KS; Jang JG; Seo EU; Kim IY; Jeon SY; Son B; Cho SW; Kim W; Ahn JH; Lee W
Proc Natl Acad Sci U S A; 2024 Jun; 121(26):e2319322121. PubMed ID: 38900789
[TBL] [Abstract][Full Text] [Related]
39. T-cell receptor signals direct the composition and function of the memory CD8+ T-cell pool.
Smith-Garvin JE; Burns JC; Gohil M; Zou T; Kim JS; Maltzman JS; Wherry EJ; Koretzky GA; Jordan MS
Blood; 2010 Dec; 116(25):5548-59. PubMed ID: 20847203
[TBL] [Abstract][Full Text] [Related]
40. Exhausted CD8
Sandu I; Cerletti D; Claassen M; Oxenius A
Nat Commun; 2020 Sep; 11(1):4454. PubMed ID: 32901001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
